Egmont Schaller

Title: The Innovations of Egmont Schaller

Introduction

Egmont Schaller is a notable inventor based in Heuweiler, Germany. He has made significant contributions to the field of pharmacology, particularly in the development of antiarrhythmic agents. His work has led to advancements that may benefit patients with heart conditions.

Latest Patents

Schaller holds a patent for "Metabolites of pirmenol." This invention relates to the + or - pirmenol stereoisomers and selected metabolites of pirmenol or (+,-)-cis-.alpha.-[3-(2,6-dimethyl-1-piperidinyl))propyl]-.alpha.-phenyl-2-pyridinemethanol. These compounds are recognized for their activity as antiarrhythmic agents. The pharmacological use of these metabolites is aimed at treating arrhythmias, and pharmaceutical compositions comprising these metabolites are also included in the scope of his invention. He has 1 patent to his name.

Career Highlights

Egmont Schaller has worked with Warner-Lambert Company, where he has been able to apply his expertise in pharmacology and contribute to innovative research. His career has been marked by a commitment to developing effective treatments for cardiovascular issues.

Collaborations

Some of his notable coworkers include Timothy R. Hurley and Dino A. Sherwood. Their collaborative efforts have likely enhanced the research and development processes within their projects.

Conclusion

Egmont Schaller's contributions to the field of pharmacology, particularly through his patent on metabolites of pirmenol, highlight his role as an influential inventor. His work continues to pave the way for advancements in antiarrhythmic treatments.